Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-05-15
1999-01-26
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514248, 514367, 514373, 514375, 514568, 544183, 544237, 548165, 548169, 548209, 548221, 548226, 548473, 548480, 562459, C07D20948, C07C 5984, C07C 5990, A61K 3119
Patent
active
058639152
ABSTRACT:
Inhibitors for matrix metalloproteases, pharmaceutical compositions containing them, and a process for using them to treat a variety of physiological conditions. The compounds of the invention have the generalized formula ##STR1## wherein R.sup.1 represents C.sub.6 -C.sub.12 alkyl; C.sub.5 -C.sub.12 alkoxy; C.sub.5 -C.sub.12 alkylthio; a polyether of formula R.sup.2 O(C.sub.2 H.sub.4 O).sub.a -- in which a is 1 or 2 and R.sup.2 is C.sub.1 -C.sub.5 alkyl, phenyl, or benzyl; and substituted alkynyl of formula R.sup.3 (CH.sub.2).sub.b --C.tbd.C--; in which b is 1-10 and R.sup.3 is H--, HO--, or R.sup.4 O-- in which R.sup.4 is C.sub.1 -C.sub.3 alkyl, phenyl, or benzyl. The alkyl, phenyl, and benzyl portions of R.sup.1 may bear at least one pharmaceutically-acceptable substituent. The subscript n is 2-4. R.sup.5 represents phenyl; imidoyl of 4-12 carbon atoms; (3H)-benzo-1,2,3-triazin-4-on-3-yl; N-saccharinyl; (2H)-phthalazin-1-on-2-yl; 2-benzoxazolin-2-on-3-yl; 5,5-dimethyloxazolidine-2,4-dion-3-yl; and thiazolidine-2,4-dion-3-yl; with the phenyl and benzo portions of R.sup.5 permissibly bearing at least one pharmaceutically-acceptable substituent. Pharmaceutically acceptable salts of these materials are also included.
REFERENCES:
patent: 5459131 (1995-10-01), Albright et al.
patent: 5684152 (1997-11-01), Ponpipom et al.
Chem. Abstract 112:56713, 1990.
Brittelli David R.
Dixon Brian R.
Kluender Harold C. E.
Bayer Corporation
Rao Deepak R.
Shah Mukund J.
LandOfFree
Substituted 4-arylbutyric acid derivatives as matrix metalloprot does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 4-arylbutyric acid derivatives as matrix metalloprot, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 4-arylbutyric acid derivatives as matrix metalloprot will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1450622